Showing results (221-230 of 281) with videos related to
Sort By:
Pageof 29
Journal of Medicinal Chemistry|April 29, 2020
Synthesis and Biochemical Evaluation of Noncyclic Nucleotide Exchange Proteins Directly Activated by cAMP 1 (EPAC1) RegulatorsPingyuan Wang, Urszula Luchowska-Stańska, Boy van Basten, et al.BMJ Open|November 1, 2018
Treatment of fatigue with physical activity and behavioural change support in vasculitis: study protocol for an open-label randomised controlled feasibility studyLorraine Harper, Matthew David Morgan, Dimitrios Chanouzas, et al.Primates; Journal of Primatology|October 8, 2024
A brief history of primate research in the Ndoki forestDavid Morgan, Richard Malonga, Marcellin Agnagna, et al.Journal of Alzheimer'S Disease : JAD|September 14, 2020
An Immunomodulatory Therapeutic Vaccine Targeting Oligomeric Amyloid-βGe Song, Haiqiang Yang, Ning Shen, et al.Alzheimer'S Research & Therapy|January 21, 2021
Differential effects of chronic immunosuppression on behavioral, epigenetic, and Alzheimer's disease-associated markers in 3xTg-AD miceMinesh Kapadia, M Firoz Mian, Donglai Ma, et al.American Journal of Primatology|December 28, 2023
Socioecological factors influencing intraspecific variation in ranging dynamics of western lowland gorillas (Gorilla gorilla gorilla) in Ndoki ForestKathryn Judson, Crickette Sanz, Thierry Fabrice Ebombi, et al.Allergy|August 31, 2023
Temporal relationships between Staphylococcus aureus colonization, filaggrin expression, and pediatric atopic dermatitisArya Dahal, Wan Chi Chang, Cassandra Almasri, et al.BMJ Global Health|July 30, 2019
The Primary Care Spend Model: a systems approach to measuring investment in primary careRobert Baillieu, Michael Kidd, Robert Phillips, et al.Frontiers in Immunology|March 9, 2026
Flat dose intravenous immunoglobulin primary infection prophylaxis in multiple myeloma patients on BCMA and GPRC5D bispecific antibody therapy: the Vanderbilt experienceNaimisha Marneni, Spencer Lessans, Bhagirathbhai Dholaria, et al.Bone Marrow Transplantation|March 25, 2025
Feasibility of axicabtagene ciloleucel in the outpatient setting: primary analysis of prospective trialBhagirathbhai Dholaria, Shakthi T Bhaskar, Vivek G Patel, et al.Pageof 29